Legend Biotech Corp - COMMON STOCK (LEGN)

CUSIP: 52490G102

Q1 2024 13F Holders as of 31 Mar 2024

Holder snapshot 7 signals
Share change
+632,836
Put/Call ratio
51%
SEC-reported price per share
$56.09
Number of holders
187
Value change
+$24,114,634
Number of buys
104
Open additional details 1 more signal available
Number of sells
96
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
388,425,868

Security key

52490G102

Report period

Q1 2024

Institutions

187

Top holders

10

Ownership snapshot

Top reported holders of LEGN - Legend Biotech Corp - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
PRICE T ROWE ASSOCIATES I...
Disclosed value leader
PRICE T ROWE ASSOCIATES I...
Comparable rows
0/15
Latest evidence
31 Dec 2023
13F Highest disclosed value: $650,332,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

PRICE T ROWE ASSOCIATES INC /MD/ has the largest disclosed position value at $650.33M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens PRICE T ROWE ASSOCIATES INC /MD/'s linked filing trail.
Disclosed position value Top 5
PRICE T ROWE ASSOCIATES INC /MD/ $650.33M
RA CAPITAL MANAGEMENT, L.P. $376.95M
HHLR ADVISORS, LTD. $360.09M
BlackRock Finance, Inc. $316.87M
Capital World Investors $143.56M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
—
denominator unverified
$650,332,000
10,808,216 shares
— 31 Dec 2023
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
—
denominator unverified
$376,947,420
6,264,707 shares
— 31 Dec 2023
HHLR ADVISORS, LTD.
13F
Company
13F
—
denominator unverified
$360,090,374
5,984,550 shares
— 31 Dec 2023
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$316,866,533
5,266,188 shares
— 31 Dec 2023
Capital World Investors
13F
Company
13F
—
denominator unverified
$143,563,213
2,385,960 shares
— 31 Dec 2023
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13F
—
denominator unverified
$138,775,547
2,306,391 shares
— 31 Dec 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
187
Shares
86,480,093
Rows available
187
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q1 2024 Across Filers

Q1 2024 holders
187
Q1 2024 holders
187
Holder diff
0
Investor Q1 2024 Shares Q1 2024 Shares Share Diff Share Chg % Q1 2024 value Q1 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .